79 related articles for article (PubMed ID: 19227008)
21. Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma.
Taoka M; Morofuji N; Yamauchi Y; Ojima H; Kubota D; Terukina G; Nobe Y; Nakayama H; Takahashi N; Kosuge T; Isobe T; Kondo T
J Proteome Res; 2014 Nov; 13(11):4847-58. PubMed ID: 24967658
[TBL] [Abstract][Full Text] [Related]
22. Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion.
Clark SS; Zhong L; Filiault D; Perman S; Ren Z; Gould M; Yang X
Clin Cancer Res; 2003 Oct; 9(12):4494-504. PubMed ID: 14555523
[TBL] [Abstract][Full Text] [Related]
23. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme.
Bambury RM; Morris PG
Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143
[TBL] [Abstract][Full Text] [Related]
24. Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines.
Bardon S; Picard K; Martel P
Nutr Cancer; 1998; 32(1):1-7. PubMed ID: 9824849
[TBL] [Abstract][Full Text] [Related]
25. Effects of perillyl alcohol on melanoma in the TPras mouse model.
Lluria-Prevatt M; Morreale J; Gregus J; Alberts DS; Kaper F; Giaccia A; Powell MB
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):573-9. PubMed ID: 12050099
[TBL] [Abstract][Full Text] [Related]
26. Investigation of serum proteome alterations in human glioblastoma multiforme.
Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.
Santos JG; Da Cruz WMS; Schönthal AH; Salazar MD; Fontes CAP; Quirico-Santos T; Da Fonseca CO
Oncol Lett; 2018 Jan; 15(1):1263-1270. PubMed ID: 29391903
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
Bai Y; Zhang QG; Wang XH
Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
[TBL] [Abstract][Full Text] [Related]
29. Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo.
Yuri T; Danbara N; Tsujita-Kyutoku M; Kiyozuka Y; Senzaki H; Shikata N; Kanzaki H; Tsubura A
Breast Cancer Res Treat; 2004 Apr; 84(3):251-60. PubMed ID: 15026623
[TBL] [Abstract][Full Text] [Related]
30. Phase I clinical trial of perillyl alcohol administered daily.
Ripple GH; Gould MN; Stewart JA; Tutsch KD; Arzoomanian RZ; Alberti D; Feierabend C; Pomplun M; Wilding G; Bailey HH
Clin Cancer Res; 1998 May; 4(5):1159-64. PubMed ID: 9607573
[TBL] [Abstract][Full Text] [Related]
31. Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis.
Chaudhary SC; Alam MS; Siddiqui MS; Athar M
Chem Biol Interact; 2009 May; 179(2-3):145-53. PubMed ID: 19161993
[TBL] [Abstract][Full Text] [Related]
32. A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia.
Stearns V; Coop A; Singh B; Gallagher A; Yamauchi H; Lieberman R; Pennanen M; Trock B; Hayes DF; Ellis MJ
Clin Cancer Res; 2004 Nov; 10(22):7583-91. PubMed ID: 15569989
[TBL] [Abstract][Full Text] [Related]
33. Proteomics in the Assessment of the Therapeutic Response of Antineoplastic Drugs: Strategies and Practical Applications.
Torres VM; Popovic L; Vaz F; Penque D
Methods Mol Biol; 2016; 1395():281-98. PubMed ID: 26910080
[TBL] [Abstract][Full Text] [Related]
34. In vitro induction of apoptosis in U937 cells by perillyl alcohol with sensitization by pentoxifylline: increased BCL-2 and BAX protein expression.
Gómez-Contreras PC; Hernández-Flores G; Ortiz-Lazareno PC; Del Toro-Arreola S; Delgado-Rizo V; Lerma-Díaz JM; Barba-Barajas M; Domínguez-Rodríguez JR; Bravo Cuellar A
Chemotherapy; 2006; 52(6):308-15. PubMed ID: 17008791
[TBL] [Abstract][Full Text] [Related]
35. Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case.
Schönthal AH; Swenson S; Bonney PA; Wagle N; Simmon VF; Mathew AJ; Hurth KM; Chen TC
J Neurosurg Case Lessons; 2022 Aug; 4(8):. PubMed ID: 36088606
[TBL] [Abstract][Full Text] [Related]
36. A pilot study of perillyl alcohol in pancreatic cancer.
Matos JM; Schmidt CM; Thomas HJ; Cummings OW; Wiebke EA; Madura JA; Patrick LJ; Crowell PL
J Surg Res; 2008 Jun; 147(2):194-9. PubMed ID: 18498869
[TBL] [Abstract][Full Text] [Related]
37. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
Hudes GR; Szarka CE; Adams A; Ranganathan S; McCauley RA; Weiner LM; Langer CJ; Litwin S; Yeslow G; Halberr T; Qian M; Gallo JM
Clin Cancer Res; 2000 Aug; 6(8):3071-80. PubMed ID: 10955786
[TBL] [Abstract][Full Text] [Related]
38. Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention.
Burke YD; Ayoubi AS; Werner SR; McFarland BC; Heilman DK; Ruggeri BA; Crowell PL
Anticancer Res; 2002; 22(6A):3127-34. PubMed ID: 12530055
[TBL] [Abstract][Full Text] [Related]
39. Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol.
Ariazi EA; Satomi Y; Ellis MJ; Haag JD; Shi W; Sattler CA; Gould MN
Cancer Res; 1999 Apr; 59(8):1917-28. PubMed ID: 10213501
[TBL] [Abstract][Full Text] [Related]
40. Changes in protein expression after neoadjuvant use of aromatase inhibitors in primary breast cancer: a proteomic approach to search for potential biomarkers to predict response or resistance.
Yiu CC; Sasano H; Ono K; Chow LW
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S79-89. PubMed ID: 20374034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
